Brief: Intensity Therapeutics Highlights 2025 Milestones And Outlines 2026 Strategic Priorities
13/01/2026 12:54
Jan 13 (Reuters) - Intensity Therapeutics Inc INTS.O: INTENSITY THERAPEUTICS HIGHLIGHTS 2025 MILESTONES AND OUTLINES 2026 STRATEGIC PRIORITIES INTENSITY THERAPEUTICS INC - PLANS TO FILE PROTOCOL AMENDMENT FOR INVINCIBLE-4 STUDY AND REINITIATE ENROLLMENT IN Q1 2026 INTENSITY THERAPEUTICS INC: TO RAISE ADDITIONAL CAPITAL DURING 2026 TO REINITIATE PATIENT ENROLLMENT AND SITE ACTIVATIONS IN INVICIBLE-3 STUDY Source text: ID:nPn5bd1b2a Further company coverage: INTS.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Intensity Therapeutics
See all newsIntensity Therapeutics Q2 net loss widens as R&D costs rise
Brief: Intensity Therapeutics Q2 Operating Income USD -3.084 Million
Intensity Therapeutics Q1 net loss narrows on lower R&D costs
Brief: Intensity Therapeutics Q1 Operating Income USD -2.526 Million
Brief: Intensity Therapeutics Inc - Increases ATM Offering Capacity To $60 Million On March 23, 2026 - SEC Filing